Nixon National Cancer Conference Examines Cancer Research Breakthroughs

n December 7 and 8, 2022, noted clinicians, researchers, journalists, NCI-designated cancer center directors, patients, patient advocates, ethicists, medical professionals and public health officials gathered for the second annual Nixon National Cancer Conference.

The conference emphasized a patient-centric and problem-centric approach to cancer care, focusing on the areas where cancer research is leading to breakthroughs across the medical spectrum.

The NNCC opened with a dinner sponsored by City of Hope Orange County and a video highlighting President Nixon’s advocacy of – and signature on – the National Cancer Act of 1971.

Other special guests at the Conference included Melanie Eisenhower, the youngest granddaughter of President and Mrs. Nixon and a child life specialist at Children’s Hospital of Philadelphia; Dr. Daniele Struppa, President of Chapman University; and Charlie Zhang, Nixon Foundation Treasurer.

Nixon Foundation President & CEO Jim Byron announced that the Richard Nixon Foundation has established the Andrew von Eschenbach Award, a new annual award that will be given to an individual whose work has contributed to advances in research and treatment that has relieved suffering and prolonged and saved lives. The first recipient will be selected for the 2024 conference. Nixon Foundation Board Member Marlene Malek joined Dr. von Eschenbach on-stage for the announcement, which included a gift to Dr. von Eschenbach of an American flag that flew over President Nixon’s Birthplace.

The

conference featured the following programs:

Mathematics, Physics and Cancer explored how converging disciplines are being applied to lead to a better understanding of the development and spread of cancer, optimizing current treatments and leading to new breakthroughs.

Panelists included:

Mauro Ferrari, University of Washington

Robert A. Gatenby, Center of Excellence for Evolutionary Therapy, University of Florida

Edward S. Kim, City of Hope Orange County and City of Hope National Medical Center

Patrick Soon-Shiong, NantWorks

Regenerative Medicine and Stem Cell Therapy explored cancer research breakthroughs in neurophysiology and neuropsychology. Panelists explained the great results in blood cancer treatments and discussed how to apply these advancements to other types of cancer. Keeping the conversation focused on the patient, panelists also discussed accessibility, community education and engagement.

Panelists included:

Stefan Ciurea, UCI Health

Stephan A. Grupp, Children’s Hospital of Philadelphia (CHOP)

Linda H. Malkas, City of Hope National Medical Center

Donald L. Trump, Inova Schar Cancer Institute

Robert Winn, VCU Massey Cancer Center

Immunology and Inflammation explored how to use our own immune systems to fight cancer. From a patient-centric point of view, the panelists discussed: 1) What are the problems? 2) What are the opportunities? and 3) What do we do about it?

Panelists included:

Anna D. Barker, Ellison Institute for Transformative Medicine at USC

Carlos Becerra, Hoag Family Cancer Institute

Carolyn Britten, Amgen

Thomas F. Gajewski, University of Chicago Comprehensive Cancer Center

A luncheon presented by the Hoag Family Cancer Institute featured a keynote address from Andrew von Eschenbach, M.D., former Director of the National Cancer Institute (NCI) and FDA Commissioner. He remarked how the National Cancer Act lives on because of the vision of Richard Nixon. Cancer and Nutrition highlighted the interplay between diet and cancer cells and explored new trends in patient care that treat food as medicine. The panelists were consulted on the lunch menu for the conference and created a menu custom-tailored with healthy ingredients.

Panelists included:

David Heber, Center for Human Nutrition at UCLA

Richard T. Lee, City of Hope Orange County

William W. Li, The Angiogenesis Foundation

Susan T. Mayne, Center for Food Safety and Applied Nutrition, FDA

Dariush Mozaffarian, Tufts Friedman School of Nutrition Science and Policy

Tech in Medicine explored how medicine and technology can come together to create cutting edge innovations to bring us closer to more cures for cancer and other diseases. Panelists debated both the opportunities and challenges of using technology in patient care including artificial intelligence, access to personal data and early detection methods.

Panelists included:

David Agus, Ellison Institute for Transformative Medicine at USC

William Cance, GRAIL

Lily Peng, Verily/Google

Peter Pisters, The University of Texas MD Anderson Cancer Center

With thanks to the 2022 Nixon National Cancer Conference supporters:

Presenting Sponsor

City of Hope Orange County

Premier Sponsors

Hoag Family Cancer Institute

Stanbridge University

UCI Health

Additional Funding

Provided by

Providence Mission Hospital

Providence St. Joseph Hospital: The Center for Cancer Prevention and Treatment

Providence St. Jude Medical Center

2022 Conference Leadership Steering Committee

Melanie Eisenhower, M.S., C.C.L.S.

Marlene Malek, R.N.

Claire Pomeroy, M.D.

Ellen Sigal, Ph.D.

Andrew von Eschenbach, M.D.

Honorary Congressional Host Committee

Hon. Don Bacon

Hon. Nanette Diaz Barragan

Hon. Stephanie Bice

Hon. Earl L “Buddy” Carter

Hon. Dianne Feinstein

Hon. Brian Fitzpatrick

Hon. Richard Hudson

Hon. Young Kim

Hon. Barry Moore

Hon. Guy Reschenthaler

Hon. Mike Rounds

Hon. Thom Tillis

Hon. Joe Wilson